Effects of weight loss on serum vitamin D in postmenopausal women

American Journal of Clinical Nutrition

Volumn 94, Issue 1, 2011, Pages 95-103

  Mason, Caitlin ^a   Xiao, Liren ^a   Imayama, Ikuyo ^a   Duggan, Catherine R ^a   Bain, Carolyn ^a   Foster Schubert, Karen E ^b   Kong, Angela ^c   Campbell, Kristin L ^d   Wang, Ching Yun ^a,b   Neuhouser, Marian L ^a,b   Li, Li ^e   Jeffery, Robert W ^f   Robien, Kim ^f   Alfano, Catherine M ^g   Blackburn, George L ^h   McTiernan, Anne ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BODY COMPOSITION; CALORIC RESTRICTION; CAUCASIAN; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; IMMUNOASSAY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; CALORIC RESTRICTION; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SUNLIGHT; VITAMIN D; WEIGHT LOSS;

EID: 79959432197     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.015552     Document Type: Article

References (43)

1. IARC Working Group on Evaluation of Cancer-Prevention Strategies. Weight control and physical activity. Vol 6. Lyon, France: IARC Press, 2002.
2. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 2009;7:414-22.
3. Beydoun MA, Boueiz A, Shroff MR, et al. Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 2010;95:3814-27.
4. Brock K, Huang WY, Fraser DR, et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 2010;121:462-6.
5. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010;59:242-8.
6. Yin L, Grandi N, Raum E, et al. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009;30:113-25.
7. Yin L, Grandi N, Raum E, et al. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010;46:2196-205.
8. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 2010;8:11-8.
9. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. (Pubitemid 351930842)
10. Ross C, Taylor CL, Yaktine AL, et al. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: National Academy of Sciences, 2010.
11. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87(suppl):1080S-6S.
12. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
13. Rayalam S, Della-Fera MA, Ambati S, et al. Enhanced effects of 1,25 (OH)(2)D(3) plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008;16:539-46.
14. Ortega RM, Lopez-Sobaler AM, Aparicio A, et al. Vitamin D status modification by two slightly hypocaloric diets in young overweight/obese women. Int J Vitam Nutr Res 2009;79:71-8.
15. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89:1321-7.
16. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009;26:19-27.
17. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations-US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005;141:477-81.
18. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
19. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24:610-28.
20. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-504.
21. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87. (Pubitemid 29144458)
22. Taylor HL, Jacobs DR Jr, Schucker B, et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-55. (Pubitemid 9140316)
23. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004;37:867-74. (Pubitemid 39209026)
24. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 2009;42:1549-56.
25. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
26. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998;6(suppl 2):51S-209S.
27. Christian JG, Tsai AG, Bessesen DH. Interpreting weight losses from lifestyle modification trials: using categorical data. Int J Obes (Lond) 2010;34:207-9.
28. Foster-Schubert KE, Alfano CM, Duggan C, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese post-menopausal women. Obesity (Silver Spring) (Epub ahead of print 14 April 2011).
29. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3. (Pubitemid 30667088)
30. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 2011;96:E447-52.
31. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225-32. (Pubitemid 47233129)
32. Riedt CS, Cifuentes M, Stahl T, et al. Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J Bone Miner Res 2005;20:455-63. (Pubitemid 40293494)
33. Tzotzas T, Papadopoulou FG, Tziomalos K, et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010;95:4251-7.
34. Holecki M, Zahorska-Markiewicz B, Janowska J, et al. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. Obesity (Silver Spring) 2007;15:1925-9. (Pubitemid 47402223)
35. Lin E, Armstrong-Moore D, Liang Z, et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) 2011;19:588-94.
36. Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998;352:167-72. (Pubitemid 28327800)
37. Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998;21:1288-94.
38. Finer N, James WP, Kopelman PG, Lean ME, Williams G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord 2000;24:306-13. (Pubitemid 30137720)
39. Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000;9:160-7.
40. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 2005;16:1425-31. (Pubitemid 41534648)
41. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med 2010;268:171-80.
42. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
43. Neuhouser ML, Sorensen B, Hollis BW, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008;88:133-9. (Pubitemid 351988692)